Blepharitis is a common eye condition characterized by inflammation and infection of the eyelids. It causes irritation, redness, and dryness around the eyelids. Blepharitis treatment involves managing the symptoms by using warm compresses, hygiene practices like lid scrubbing, and topical antibiotic ointments or drops. In severe cases, oral antibiotics may be prescribed. The global blepharitis treatment market is driven by the increasing awareness regarding management of blepharitis through effective treatment options and home remedies. The global Blepharitis Treatment Market is estimated to be valued at US$ 2.5 Bn in 2023 and is expected to exhibit a CAGR of 10 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increased adoption of eyelid hygiene practices like warm compress therapy and lid scrubs is a major trend fueling the blepharitis treatment market growth. According to recent studies, regular eyelid cleaning helps remove dirt, debris and reduce bacterial build-up which are some of the major causes of blepharitis. This has raised awareness about simple eyelid hygiene practices as the first line of treatment for managing mild blepharitis symptoms without medications. Various eye care product manufacturers are moreover promoting eyelid cleaning kits and warm compress products for over-the-counter blepharitis treatment.
Strength: Blepharitis treatment products are aimed at providing relief from redness, itchiness, swelling and dryness associated with blepharitis. Efficient treatment options are available in the market.
Weakness: Lack of awareness about blepharitis as a medical condition. Differentiating it from other common eye problems can be challenging.
Opportunity: Growing aging population prone to eye disorders provides scope for blepharitis treatment market expansion. Rising healthcare expenditure in developing nations also opens new opportunities.
Threats: Strong competition from alternative eye care products. Side effects of certain blepharitis medicines restrict their use in some cases.
The global blepharitis treatment market is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis indicates that North America currently dominates due to high blepharitis prevalence and diagnostic rates. Growing healthcare expenditure is also supporting market growth in the region.
Key players operating in the blepharitis treatment are Scope Ophthalmic Ltd., NovaBay Pharmaceuticals Inc., Thea Pharmaceuticals Ltd., Perrigo Laboratories, InSite Vision Incorporated, Merck & Co., and Novartis AG. These companies offer a wide range of prescription eye drops, ointments, artificial tears and warm compresses for blepharitis treatment.
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it